´ëÇѺÎÁ¤¸ÆÇÐȸ (¿Â¶óÀÎ) VT (Ventricular Tachycardia) Symposium 2021 : 2021-11-13±³À°ÀÏÀÚ : 2021-11-13
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) VT (Ventricular Tachycardia) Symposium 2021ÁÖÃÖ±â°ü : ´ëÇѺÎÁ¤¸ÆÇÐȸ
´ã´çÀÚ : ±èÈ¿Á¤
¿¬¶ôó : 02-318-5416
À̸ÞÀÏ :
khrs9@k-hrs.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í ÀÇ»ç(Àü¹®ÀÇ, Àü°øÀÇ, ÀüÀÓÀÇ) : 2¸¸¿ø / ±âŸ: 1¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11-13 ¿Â¶óÀÎ 08:50~08:55 Opening Remarks ÇѼº¿í(°è¸íÀÇ´ë)
±âŸ 11-13 ¿Â¶óÀÎ 08:55~09:00 Congratulatory Remarks À̹®Çü(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 09:00~09:10 Utilizing ECG(Electrocardiogram) to Stratify SCD(Sudden Cardiac Death) Risk in CHD(Coronary Heart Disease) Patients with LVEF(Left Ventricular Ejection Fraction)>35% Á¶¹Î¼ö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 09:10~09:20 Risk Stratification of SCD(Sudden Cardiac Death) in Post MI(Myocardial Infraction) Patients/Nonischemic CM(Cardiomyopathy) Patients Á¶¿µÁø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 09:20~09:30 Sympathetic Neuromodulation for Management of VT(Ventricular Tachycardia) ±ÇâÈñ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 09:30~09:40 Approach for Diagnosing Idiopathic VF(Ventricular Fibrillation) ±è¼ºÈ¯(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 09:40~09:50 Appropriate Timing of ICD(Implantable Cardioverter Defibrillator) for The Primary Prevention: What's The Optimal Duration of Medications, Including ARNI(Antiotensin Receptor Neprilysin Inhibitor)? ±èÁÖ¿¬(¼º±Õ°üÀÇ´ë)
Åä·Ð 11-13 ¿Â¶óÀÎ 09:50~10:10 Discussion ()
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 10:10~10:20 Changing Paradigms in SCD(Sudden Cardiac Death) À̼ҷÉ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 10:20~10:30 Redefining Sudden Cardiac Death: Insights The San Francisco POST SCD(Sudden Cardiac Death) Study À±³²½Ä(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 10:30~10:40 Racial Differences in SCD(Sudden Cardiac Death) Risk ¹ÚÇü¼·(°è¸íÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 10:40~10:50 SCD(Sudden Cardiac Death) in Mitral Valve Prolapse ³ë½Â¿µ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 10:50~11:00 Sudden Death Risk in Patients with PVCs(Premature Ventricular Contraction) ±èÀ¯¸®(µ¿±¹ÀÇ´ë)
Åä·Ð 11-13 ¿Â¶óÀÎ 11:00~11:20 Discussion ()
ÈÞ½Ä 11-13 ¿Â¶óÀÎ 11:20~11:30 Break Time ()
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 11:30~11:40 What Should be Considered During Implantation, Single vs. Dual Coil, Transvenous vs. Subcutaneous Etc? ¹ÚÇü¿í(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 11:40~11:50 Is The ATP(Adenocine Triphosphate) Necessary for The Device Setting? ÃÖÀDZÙ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 11:50~12:00 How to Set The ICD(Implantable Cardioverter Defibrillator) Parameters, How to Avoid Unnecessary or Inappropriate Treatment ÀÌÁöÇö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 12:00~12:10 How to Manage The VT(Ventricular Tachycardia) or VF(Ventricular Fibrillation) Episodes During Follow Up ±èÁø¹è(°æÈñÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 12:10~12:20 How to Manage The VT(Ventricular Tachycardia) Storm, Including The Timing of Catheter Ablation and Sympathetic Blockade ÀÌ¿µ¼ö(´ë±¸°¡Å縯ÀÇ´ë)
Åä·Ð 11-13 ¿Â¶óÀÎ 12:20~12:40 Discussion ()
½Ä»ç 11-13 ¿Â¶óÀÎ 12:40~13:30 Lunch ()
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 13:30~13:40 Anatomy/Ablation of LV(Left Ventricular) Outflow Tract PVC(Premature Ventricular Contraction)/VT(Ventricular Tachycardia) À̱âÈ«(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 13:40~13:50 Cardiac Vein Mapping for PVCs(Premature Ventricular Contraction) ¾öÀç¼±(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 13:50~14:00 Ablation of Focal Intramural VA(Ventricular Arrhythmia)s Targeting The Site of Origin ÃÖÁ¾ÀÏ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 14:00~14:10 ICE(Intracardiac Echocardiography) Imaging for Idiopathic VT(Ventricular Tachycardia) °ûÇýºó(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 14:10~14:20 Improving Outcome of Ablation for Papillary Muscle VT(Ventricular Tachycardia) ¹Ú¿¹¹Î(°¡ÃµÀÇ´ë)
Åä·Ð 11-13 ¿Â¶óÀÎ 14:20~14:40 Discussion ()
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 14:40~14:50 Natural History of Arrhythmias After ICD(Implantable Cardioverter Defibrillator) Implant: PARTITA Lessons ¹Ú»ó¿ø(ºÎõ ¼¼Á¾º´¿ø)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 14:50~15:00 Resynchronization with His and LV(Left Ventricular) Pacing ¹Ú½ÂÁ¤(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 15:00~15:10 Should DFT(Defibrillation Threshold) Testing be Required in S-ICD(Subcutaneous Implantable Cardioverter Defibrillator)? ³²±ÃÁØ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 15:10~15:20 New Leadless ICD(Implantable Cardioverter Defibrillator) Technologies ±èÅÂÈÆ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-13 ¿Â¶óÀÎ 15:20~15:30 Does Recovery of EF(Ejection Fraction) Preclude ICD(Implantable Cardioverter Defibrillator) Generator Replacement? ¹é¿ë¼ö(ÀÎÇÏÀÇ´ë)
Åä·Ð 11-13 ¿Â¶óÀÎ 15:30~15:50 Discussion ()
±âŸ 11-13 ¿Â¶óÀÎ 15:50~16:00 Closing Remarks ÇѼº¿í(°è¸íÀÇ´ë)